Avalo Therapeutics Inc (AVTX)
11.97
-1.53
(-11.33%)
USD |
NASDAQ |
May 08, 16:00
12.00
+0.03
(+0.25%)
After-Hours: 20:00
Avalo Therapeutics Cash from Operations (Quarterly): -2.766M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -2.766M |
| September 30, 2023 | -6.836M |
| June 30, 2023 | -11.03M |
| March 31, 2023 | -10.05M |
| December 31, 2022 | -3.94M |
| September 30, 2022 | 5.726M |
| June 30, 2022 | -12.47M |
| March 31, 2022 | -16.07M |
| December 31, 2021 | -17.10M |
| September 30, 2021 | -16.29M |
| June 30, 2021 | -19.19M |
| March 31, 2021 | -18.32M |
| December 31, 2020 | -14.38M |
| September 30, 2020 | -11.87M |
| June 30, 2020 | -8.555M |
| March 31, 2020 | -5.739M |
| December 31, 2019 | -1.680M |
| September 30, 2019 | -7.615M |
| June 30, 2019 | -6.717M |
| March 31, 2019 | -3.122M |
| Date | Value |
|---|---|
| December 31, 2018 | -1.976M |
| September 30, 2018 | -0.5383M |
| June 30, 2018 | -0.3337M |
| March 31, 2018 | -0.2804M |
| December 31, 2017 | -2.549M |
| September 30, 2017 | 19.12M |
| June 30, 2017 | -1.759M |
| March 31, 2017 | -2.236M |
| December 31, 2016 | -3.713M |
| September 30, 2016 | -3.434M |
| June 30, 2016 | -3.720M |
| March 31, 2016 | -3.707M |
| December 31, 2015 | -3.548M |
| September 30, 2015 | -1.815M |
| June 30, 2015 | -1.731M |
| March 31, 2015 | -3.069M |
| December 31, 2014 | -3.968M |
| September 30, 2014 | -7.100M |
| June 30, 2014 | -2.238M |
| March 31, 2014 | -2.212M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-19.19M
Minimum
Jun 2021
5.726M
Maximum
Sep 2022
-9.730M
Average
-10.05M
Median
Mar 2023
Cash from Operations (Quarterly) Benchmarks
| Imunon Inc | -3.772M |
| iBio Inc | -4.706M |
| Kodiak Sciences Inc | -32.24M |
| Petros Pharmaceuticals Inc | -2.260M |
| Ocugen Inc | -11.30M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Financing (Quarterly) | 0.001M |
| Free Cash Flow | -30.68M |
| Free Cash Flow Per Share (Quarterly) | -3.45 |
| Free Cash Flow to Equity (Quarterly) | -2.766M |
| Free Cash Flow to Firm (Quarterly) | -2.766M |
| Free Cash Flow Yield | -928.9% |